Completed PHASE2 INTERVENTIONAL 2-arm NCT02407262

Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes

Sponsor: King Abdulaziz University

Conditions Asthma

Updated 5 times since 2017 Last updated: May 10, 2016 Started: May 31, 2015 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02407262, this PHASE2 trial focuses on Asthma and remains completed. Sponsored by King Abdulaziz University, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Abdulaziz University
University College, London

Data source: University College, London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeddah, Saudi Arabia